CV Sciences annual operating margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
CV Sciences's operating margin was −3.41% for fiscal 2025.
View full CV Sciences company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −3.41% | +10.54 pp |
| 2024 | 2024-12-31 | −13.94% | −34.94 pp |
| 2023 | 2023-12-31 | 20.99% | +63.25 pp |
| 2022 | 2022-12-31 | −42.25% | +49.76 pp |
| 2021 | 2021-12-31 | −92.01% | +0.47 pp |
| 2020 | 2020-12-31 | −92.48% | −60.37 pp |
| 2019 | 2019-12-31 | −32.11% | −53.35 pp |
| 2018 | 2018-12-31 | 21.24% | +44.74 pp |
| 2017 | 2017-12-31 | −23.50% | +94.70 pp |
| 2016 | 2016-12-31 | −118.20% | −20.97 pp |
| 2015 | 2015-12-31 | −97.23% | −13.29 pp |
| 2014 | 2014-12-31 | −83.93% | −8.85 pp |
| 2013 | 2013-12-31 | −75.08% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −10.08% | −6.46 pp |
| Q1 2026 | 2026-03-31 | −9.95% | −10.26 pp |
| Q4 2025 | 2025-12-31 | −2.27% | +14.36 pp |
| Q3 2025 | 2025-09-30 | −8.45% | +0.38 pp |
| Q2 2025 | 2025-06-30 | −3.62% | +11.13 pp |
| Q1 2025 | 2025-03-31 | 0.31% | +15.80 pp |
| Q4 2024 | 2024-12-31 | −16.63% | +6.76 pp |
| Q3 2024 | 2024-09-30 | −8.82% | +1.86 pp |
| Q2 2024 | 2024-06-30 | −14.74% | +12.39 pp |
| Q1 2024 | 2024-03-31 | −15.49% | −154.40 pp |
| Q4 2023 | 2023-12-31 | −23.39% | +31.54 pp |
| Q3 2023 | 2023-09-30 | −10.69% | +13.09 pp |
| Q2 2023 | 2023-06-30 | −27.13% | +28.81 pp |
| Q1 2023 | 2023-03-31 | 138.91% | +172.98 pp |
| Q4 2022 | 2022-12-31 | −54.92% | +123.04 pp |
| Q3 2022 | 2022-09-30 | −23.78% | +34.57 pp |
| Q2 2022 | 2022-06-30 | −55.94% | +12.50 pp |
| Q1 2022 | 2022-03-31 | −34.07% | +30.20 pp |
| Q4 2021 | 2021-12-31 | −177.96% | +4.07 pp |
| Q3 2021 | 2021-09-30 | −58.35% | −1.72 pp |
| Q2 2021 | 2021-06-30 | −68.45% | +17.86 pp |
| Q1 2021 | 2021-03-31 | −64.27% | +0.06 pp |
| Q4 2020 | 2020-12-31 | −182.04% | −103.32 pp |
| Q3 2020 | 2020-09-30 | −56.63% | −42.56 pp |
| Q2 2020 | 2020-06-30 | −86.30% | −93.75 pp |
| Q1 2020 | 2020-03-31 | −64.33% | −1.44 pp |
| Q4 2019 | 2019-12-31 | −78.72% | −98.10 pp |
| Q3 2019 | 2019-09-30 | −14.07% | −39.99 pp |
| Q2 2019 | 2019-06-30 | 7.44% | −19.26 pp |
| Q1 2019 | 2019-03-31 | −62.89% | −71.17 pp |
| Q4 2018 | 2018-12-31 | 19.38% | +17.51 pp |
| Q3 2018 | 2018-09-30 | 25.92% | +34.54 pp |
| Q2 2018 | 2018-06-30 | 26.70% | +47.76 pp |
| Q1 2018 | 2018-03-31 | 8.28% | +105.34 pp |
| Q4 2017 | 2017-12-31 | 1.87% | +258.10 pp |
| Q3 2017 | 2017-09-30 | −8.62% | +45.12 pp |
| Q2 2017 | 2017-06-30 | −21.06% | +61.86 pp |
| Q1 2017 | 2017-03-31 | −97.07% | −47.31 pp |
| Q4 2016 | 2016-12-31 | −256.23% | −6.22 pp |
| Q3 2016 | 2016-09-30 | −53.73% | −32.00 pp |
| Q2 2016 | 2016-06-30 | −82.92% | −0.25 pp |
| Q1 2016 | 2016-03-31 | −49.76% | +49.21 pp |
| Q4 2015 | 2015-12-31 | −250.01% | +74.17 pp |
| Q3 2015 | 2015-09-30 | −21.73% | +4.63 pp |
| Q2 2015 | 2015-06-30 | −82.67% | −87.06 pp |
| Q1 2015 | 2015-03-31 | −98.96% | −119.31 pp |
| Q4 2014 | 2014-12-31 | −324.18% | −162.25 pp |
| Q3 2014 | 2014-09-30 | −26.36% | +386.84 pp |
| Q2 2014 | 2014-06-30 | 4.39% | +308.62 pp |
| Q1 2014 | 2014-03-31 | 20.35% | −42.71 pp |
| Q4 2013 | 2013-12-31 | −161.93% | — |
| Q3 2013 | 2013-09-30 | −413.20% | — |
| Q2 2013 | 2013-06-30 | −304.24% | — |
| Q1 2013 | 2013-03-31 | 63.06% | — |
Over the last five reported fiscal years, CV Sciences's operating margin increased from −92.48% to −3.41%, a change of +89.07 percentage points. The latest reported quarter, Q2 2026, shows −10.08%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CV Sciences filings at SEC.gov ↗